CDL Nuclear · Anchor Notes
Anchor Note · CDL Nuclear

Call Extraction: CDL x MedScout Check-in

Date
Friday, December 12, 2025
Format
Gong · ~20 minutes
Participants
Phil Cranmer · Meaghan DePeter

Call Extraction: CDL x MedScout Check-in

DDX ID: 0101 Date: 2025-12-12 Duration: ~20 minutes Participants: Phil Cranmer — CDL Nuclear. Meaghan DePeter — MedScout. Call type: Regular check-in, license expansion approval, product feedback relay. Triage: Moderate-rich. The Rhode Island patient journey use case and Kendall’s CON work are the strongest material. Provider lookup workflow friction is platform feedback, not fingerprint. 3 distinct insights.

Distinct Insights

1. CDL uses patient journey claims data to build regulatory (CON) business cases

What: Kendall (CDL attorney handling CON applications) and Dr. Mazza are tracking Rhode Island patients who get SPECT scans locally but travel to Lawrence, Massachusetts for PET scans. Phil: “This will allow them to click into an opportunity where, and not only see the spec volumes but see where else those patients may have gone for ct, whether it be in state or Massachusetts.” Meaghan confirmed: “We are tracking that patient through the claim and understanding that they started in Rhode Island at cardiovascular institute, and then ultimately, they had to go to Lawrence, Massachusetts to get their pet scan.”

So what: CDL isn’t just using claims data for sales targeting — they’re using it for regulatory strategy. Certificate of Need (CON) states require proof of demand before approving new medical equipment installations. The traditional approach would be surveys or anecdotal evidence. CDL is instead building a quantitative case: here are X patients who received SPECT in Rhode Island but had to cross state lines for PET, proving unmet local demand. This is a different value chain for claims data entirely — it moves from “help sales reps find prospects” to “help the legal team overcome regulatory barriers.” Kendall handles CON applications in ~20 states (per context), so if this methodology works in Rhode Island, it becomes a repeatable playbook for every CON state where CDL wants to place equipment. The patient journey tracking converts a regulatory obstacle into a data-driven argument.

Speaker credibility: Phil and Meaghan describing an active use case with Kendall and Dr. Mazza. High — this is happening now, not theoretical. Scope: CON regulatory strategy — applies to ~20 states where CDL needs CON approval. Motion: Both (CON affects both hospital and private practice installations, though likely more hospital-weighted).

2. Phil approves license expansion instantly when the user demonstrates value — ROI-gated spending

What: Phil asked if there were open licenses. When told all 16 seats were occupied, Meaghan quoted $210/month for an additional license. Phil’s decision process: “He made the request to get access. So as long as he’s seeing the value in it, which it sounds like he is… let’s just get him a let’s add him and get him a license.” No hesitation, no budget review, no approval chain mentioned.

So what: CDL’s license investment model is value-demonstrated, not top-down allocated. Phil doesn’t pre-buy licenses speculatively; he fills them based on who’s actively using the platform and finding value. Kendall got a license because his Rhode Island work proved the platform was useful for his regulatory function. This means CDL’s platform expansion is organic and bottom-up at the user level — individual team members demonstrate a use case, Phil validates it, and licenses grow. The flip side: if a user stops finding value, Phil would presumably reallocate that license. This approach means CDL’s seat count is a lagging indicator of value delivery, not a leading indicator of commitment. Every occupied seat represents a validated use case.

Speaker credibility: Phil, making a real-time spending decision. Very high. Scope: Company-wide license management approach. Motion: Both.

3. CDL wants to replicate the Rhode Island patient journey methodology across territories

What: Meaghan: “He expressed interest that he might be able to do this for other entities or territories per se.” Phil confirmed openness: “Okay? So up to you, I can, I’m more than happy to have another call with Kendall if you want to realign with him.”

So what: If the Rhode Island patient journey analysis successfully supports PET approval, CDL plans to use the same approach in other markets with similar regulatory barriers. This means the CON business case methodology (Insight #1) isn’t a one-off — Kendall intends to systematize it. Each CON state where CDL operates potentially gets its own patient journey analysis showing local SPECT patients traveling out-of-state for PET. This would make claims data a recurring input to CDL’s regulatory function, not just a sales tool. The scale here matters: ~20 CON states means up to 20 potential replications of this analysis, each building the case for a new CDL equipment placement.

Speaker credibility: Meaghan relaying Kendall’s interest, confirmed by Phil. Medium-high — interest expressed but not yet executed beyond Rhode Island. Scope: National regulatory strategy. Motion: Both.

Transcription Notes

  • “kindle”/“kindle’s” throughout the transcript is a transcription error for Kendall (Kendall Thiessen, CDL attorney handling CON applications).
  • Dr. Mazza — Rhode Island cardiologist working with Kendall on the CON case. Not previously in the term bank.
  • Rob referenced as “VP West Private Practice” — this is Robb Gosling. The MDCN doesn’t use his last name here but maps to known context.
  • “ct” in the transcript context of “spec to ct” — this appears to be the MDCN processor using “ct” where the actual discussion is about PET. CDL’s strategy center shows “spec to ct” as a strategy name, which may be a configuration label rather than a transcription error. Worth flagging: “ct” in this context may actually mean PET, since the entire discussion is about tracking patients from SPECT to PET imaging, not SPECT to CT.
  • 16 license holders named: Carmen, Dale, Doug, Jessica, Joe, Laura, Lynette, Patrick, Phil, Rob, Sam, Scott, Sean, Todd, Tricia, Wayne. This is the most complete CDL user roster captured in any transcript.